GENERAL PHARMACOLOGICAL PROPERTIES OF UFT A NEW TYPE OF ANTI-CANCER AGENT CONSISTING OF 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL (FT) AND URACIL. I: PHARMACOLOGICAL ANALYSIS OF THE COMBINED EFFECT OF FT AND URACILYAMAMOTO J; TOIDE K; HARUNO A et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 8; PP. 1268-1278; ABS. GER; BIBL. 25 REF.Article

Preliminary study of the optimal dosing schedule for oral UFT/leucovorin chemotherapySADAHIRO, Sotaro; SUZUKI, Toshiyuki; ISHIKAWA, Kenji et al.Anticancer research. 2004, Vol 24, Num 2B, pp 625-630, issn 0250-7005, 6 p.Article

Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulationMILANO, G; FERRERO, J.-M; FRANCOIS, E et al.British journal of cancer. 2004, Vol 91, Num 4, pp 613-617, issn 0007-0920, 5 p.Article

Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancerLEE, Keun-Wook; YU JUNG KIM; JEE HYUN KIM et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 3, pp 447-455, issn 0344-5704, 9 p.Article

The role of UFT in advanced gastric cancerAYKAN, N. F; IDELEVICH, E.Annals of oncology. 2008, Vol 19, Num 6, pp 1045-1052, issn 0923-7534, 8 p.Article

Poorly differentiated adenocarcinoma in the ascending colon with peritoneal dissemination: case report of a patient who survived more than eleven yearsSATO, Harunobu; MAEDA, Koutarou; KURODA, Makoto et al.Acta gastro-enterologica belgica (English ed.). 2008, Vol 71, Num 3, pp 321-324, issn 1784-3227, 4 p.Article

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in JapanICHINOSE, Yukito.Cancer chemotherapy and pharmacology. 2006, Vol 58, issn 0344-5704, s43-s48, SUP1Conference Paper

Le cétuximab à l'ESMO 2006 : Istanbul, du 29 septembre au 3 octobre 2006ARTRU, Pascal; LLEDO, Gérard.La Lettre du cancérologue (Boulogne). 2006, Vol 15, Num 7, issn 1165-113X, 7 p., SUP1Serial Issue

UFT plus gemcitabine combination chemotherapy in patients with advanced non-small-cell lung cancer : a multi-institutional phase II trialICHINOSE, Y; SETO, T; SEMBA, H et al.British journal of cancer. 2005, Vol 93, Num 7, pp 770-773, issn 0007-0920, 4 p.Article

Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancerURIEN, S; FUMOLEAU, P; CAMPONE, M et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 2, pp 99-107, issn 0344-5704, 9 p.Article

Dual modulation of UFT with leucovorin and hydroxyurea in metastatic colorectal cancerJAKOBSEN, Anders; PFEIFFER, Per; HANSEN, Flemming et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 1, pp 63-66, issn 0284-186XArticle

Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracilNIO, Y; SHIRAISHI, T; TSUBONO, M et al.Anticancer research. 1991, Vol 11, Num 2, pp 607-612, issn 0250-7005, 6 p.Article

Safety of UFT/LV and S-I as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trialMOCHIZUKI, I; TAKIUCHI, H; MOCHIZUKI, H et al.British journal of cancer. 2012, Vol 106, Num 7, pp 1268-1273, issn 0007-0920, 6 p.Article

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancerHOFF, P. M; KOPETZ, S; THOMAS, M. B et al.British journal of cancer. 2008, Vol 99, Num 5, pp 722-726, issn 0007-0920, 5 p.Article

An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancerSAKAMOTO, J; HAMADA, C; YOSHIDA, S et al.British journal of cancer. 2007, Vol 96, Num 8, pp 1170-1177, issn 0007-0920, 8 p.Article

Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer : a Phase I studySHEIKH, H. Y; VALLE, J. W; PALMER, K et al.British journal of cancer. 2007, Vol 96, Num 1, pp 38-43, issn 0007-0920, 6 p.Article

Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreasFELIU, J; GARCIA SAENZ, J; LEON, A et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 4, pp 419-426, issn 0344-5704, 8 p.Article

Immunohistochemical expression of HER-1 and HER-2 in extrahepatic biliary carcinomaOGO, Yasumasa; NIO, Yoshinori; YANO, Seiji et al.Anticancer research. 2006, Vol 26, Num 1B, pp 763-770, issn 0250-7005, 8 p.Article

Clinical outcome of oral uracil/tegafur (UFT) therapy for patients with hormone refractory prostate cancerMIYAKE, Hideaki; HARA, Isao; YAMAZAKI, Hiroshi et al.Oncology reports. 2005, Vol 14, Num 3, pp 673-676, issn 1021-335X, 4 p.Article

Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynxRIVERA, Fernando; VEGA-VILLEGAS, Maria E; SANZ-ORTIZ, Jaime et al.The Laryngoscope. 2004, Vol 114, Num 7, pp 1163-1169, issn 0023-852X, 7 p.Article

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. CommentaryENDO, Chiaki; SAITO, Yasuki; FUJIMURA, Shigefumi et al.Lung cancer. 2003, Vol 40, Num 2, pp 181-190, issn 0169-5002, 10 p.Article

Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinomaTAGUCHI, Takahide; IKEDA, Yoichi; MIKAMI, Yasukazu et al.Anticancer research. 2003, Vol 23, Num 1B, pp 713-717, issn 0250-7005, 5 p.Article

A potential imortant role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexedKABESHIMA, Yasuo; KUBOTA, Tetsuro; WATANABE, Masahiko et al.Anticancer research. 2002, Vol 22, Num 6A, pp 3245-3252, issn 0250-7005, 8 p.Article

In vivo evidence for a significant role of folylpolyglutamate synthase in combined chemotherapy with oral fluoropyrimidine, UFT or S-1, and leucovorinTSUKIOKA, Sayaka; SAKAMOTO, Etsuko; TSUJIMOTO, Hiroaki et al.Oncology reports. 2011, Vol 25, Num 5, pp 1407-1412, issn 1021-335X, 6 p.Article

Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastasesYAMAGUCHI, Tatsuro; MATSUMOTO, Hiroshi; YASUTOME, Michiya et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 629-635, issn 0344-5704, 7 p.Article